Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Programmed longevity, youthspan, and juventology.

Identifieur interne : 000258 ( Main/Exploration ); précédent : 000257; suivant : 000259

Programmed longevity, youthspan, and juventology.

Auteurs : Valter D. Longo [États-Unis, Italie]

Source :

RBID : pubmed:30334314

Descripteurs français

English descriptors

Abstract

The identification of conserved genes and pathways that regulate lifespan but also healthspan has resulted in an improved understanding of the link between nutrients, signal transduction proteins, and aging but has also provided evidence for the existence of multiple "longevity programs," which are selected based on the availability of nutrients. Periodic fasting and other dietary restrictions can promote entry into a long-lasting longevity program characterized by cellular protection and optimal function but can also activate regenerative processes that lead to rejuvenation, which are independent of the aging rate preceding the restricted period. Thus, a "juventology"-based strategy can complement the traditional gerontology approach by focusing not on aging but on the longevity program affecting the life history period in which mortality is very low and organisms remain youthful, healthy, and fully functional.

DOI: 10.1111/acel.12843
PubMed: 30334314
PubMed Central: PMC6351819


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Programmed longevity, youthspan, and juventology.</title>
<author>
<name sortKey="Longo, Valter D" sort="Longo, Valter D" uniqKey="Longo V" first="Valter D" last="Longo">Valter D. Longo</name>
<affiliation wicri:level="2">
<nlm:affiliation>University of Southern California, Los Angeles, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>University of Southern California, Los Angeles</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Regenerative Medicine and Stem Cell Research at USC, Keck School of Medicine, University of Southern California, Los Angeles, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Center for Regenerative Medicine and Stem Cell Research at USC, Keck School of Medicine, University of Southern California, Los Angeles</wicri:cityArea>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>IFOM FIRC Institute of Molecular Oncology, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>IFOM FIRC Institute of Molecular Oncology, Milan</wicri:regionArea>
<placeName>
<settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30334314</idno>
<idno type="pmid">30334314</idno>
<idno type="doi">10.1111/acel.12843</idno>
<idno type="pmc">PMC6351819</idno>
<idno type="wicri:Area/Main/Corpus">000432</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000432</idno>
<idno type="wicri:Area/Main/Curation">000432</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000432</idno>
<idno type="wicri:Area/Main/Exploration">000432</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Programmed longevity, youthspan, and juventology.</title>
<author>
<name sortKey="Longo, Valter D" sort="Longo, Valter D" uniqKey="Longo V" first="Valter D" last="Longo">Valter D. Longo</name>
<affiliation wicri:level="2">
<nlm:affiliation>University of Southern California, Los Angeles, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>University of Southern California, Los Angeles</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Regenerative Medicine and Stem Cell Research at USC, Keck School of Medicine, University of Southern California, Los Angeles, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Center for Regenerative Medicine and Stem Cell Research at USC, Keck School of Medicine, University of Southern California, Los Angeles</wicri:cityArea>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>IFOM FIRC Institute of Molecular Oncology, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>IFOM FIRC Institute of Molecular Oncology, Milan</wicri:regionArea>
<placeName>
<settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Aging cell</title>
<idno type="eISSN">1474-9726</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Animals (MeSH)</term>
<term>Caloric Restriction (MeSH)</term>
<term>Cyclic AMP-Dependent Protein Kinases (antagonists & inhibitors)</term>
<term>Diet, Protein-Restricted (MeSH)</term>
<term>Fasting (physiology)</term>
<term>Free Radicals (adverse effects)</term>
<term>Growth Hormone (antagonists & inhibitors)</term>
<term>Humans (MeSH)</term>
<term>Insulin-Like Growth Factor I (antagonists & inhibitors)</term>
<term>Life Expectancy (MeSH)</term>
<term>Longevity (genetics)</term>
<term>Mice (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Nutrients (physiology)</term>
<term>Rejuvenation (physiology)</term>
<term>Ribosomal Protein S6 Kinases (antagonists & inhibitors)</term>
<term>Saccharomyces cerevisiae (metabolism)</term>
<term>Sirolimus (pharmacology)</term>
<term>TOR Serine-Threonine Kinases (antagonists & inhibitors)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Animaux (MeSH)</term>
<term>Cyclic AMP-Dependent Protein Kinases (antagonistes et inhibiteurs)</term>
<term>Espérance de vie (MeSH)</term>
<term>Facteur de croissance IGF-I (antagonistes et inhibiteurs)</term>
<term>Hormone de croissance (antagonistes et inhibiteurs)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Jeûne (physiologie)</term>
<term>Longévité (génétique)</term>
<term>Nutriments (physiologie)</term>
<term>Radicaux libres (effets indésirables)</term>
<term>Rajeunissement (physiologie)</term>
<term>Restriction calorique (MeSH)</term>
<term>Ribosomal Protein S6 Kinases (antagonistes et inhibiteurs)</term>
<term>Régime pauvre en protéines (MeSH)</term>
<term>Saccharomyces cerevisiae (métabolisme)</term>
<term>Sirolimus (pharmacologie)</term>
<term>Souris (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Sérine-thréonine kinases TOR (antagonistes et inhibiteurs)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Free Radicals</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Cyclic AMP-Dependent Protein Kinases</term>
<term>Growth Hormone</term>
<term>Insulin-Like Growth Factor I</term>
<term>Ribosomal Protein S6 Kinases</term>
<term>TOR Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Cyclic AMP-Dependent Protein Kinases</term>
<term>Facteur de croissance IGF-I</term>
<term>Hormone de croissance</term>
<term>Ribosomal Protein S6 Kinases</term>
<term>Sérine-thréonine kinases TOR</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Radicaux libres</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Longevity</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Longévité</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Sirolimus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Sirolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Jeûne</term>
<term>Nutriments</term>
<term>Rajeunissement</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Fasting</term>
<term>Nutrients</term>
<term>Rejuvenation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Caloric Restriction</term>
<term>Diet, Protein-Restricted</term>
<term>Humans</term>
<term>Life Expectancy</term>
<term>Mice</term>
<term>Middle Aged</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Espérance de vie</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Restriction calorique</term>
<term>Régime pauvre en protéines</term>
<term>Souris</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The identification of conserved genes and pathways that regulate lifespan but also healthspan has resulted in an improved understanding of the link between nutrients, signal transduction proteins, and aging but has also provided evidence for the existence of multiple "longevity programs," which are selected based on the availability of nutrients. Periodic fasting and other dietary restrictions can promote entry into a long-lasting longevity program characterized by cellular protection and optimal function but can also activate regenerative processes that lead to rejuvenation, which are independent of the aging rate preceding the restricted period. Thus, a "juventology"-based strategy can complement the traditional gerontology approach by focusing not on aging but on the longevity program affecting the life history period in which mortality is very low and organisms remain youthful, healthy, and fully functional.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">30334314</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>02</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1474-9726</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>18</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2019</Year>
<Month>02</Month>
</PubDate>
</JournalIssue>
<Title>Aging cell</Title>
<ISOAbbreviation>Aging Cell</ISOAbbreviation>
</Journal>
<ArticleTitle>Programmed longevity, youthspan, and juventology.</ArticleTitle>
<Pagination>
<MedlinePgn>e12843</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/acel.12843</ELocationID>
<Abstract>
<AbstractText>The identification of conserved genes and pathways that regulate lifespan but also healthspan has resulted in an improved understanding of the link between nutrients, signal transduction proteins, and aging but has also provided evidence for the existence of multiple "longevity programs," which are selected based on the availability of nutrients. Periodic fasting and other dietary restrictions can promote entry into a long-lasting longevity program characterized by cellular protection and optimal function but can also activate regenerative processes that lead to rejuvenation, which are independent of the aging rate preceding the restricted period. Thus, a "juventology"-based strategy can complement the traditional gerontology approach by focusing not on aging but on the longevity program affecting the life history period in which mortality is very low and organisms remain youthful, healthy, and fully functional.</AbstractText>
<CopyrightInformation>© 2018 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Longo</LastName>
<ForeName>Valter D</ForeName>
<Initials>VD</Initials>
<AffiliationInfo>
<Affiliation>University of Southern California, Los Angeles, California.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Center for Regenerative Medicine and Stem Cell Research at USC, Keck School of Medicine, University of Southern California, Los Angeles, California.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>IFOM FIRC Institute of Molecular Oncology, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P01AG055369</GrantID>
<Agency>NIA/NIH</Agency>
<Country>International</Country>
</Grant>
<Grant>
<GrantID>R01AG020642</GrantID>
<Agency>NIA/NIH</Agency>
<Country>International</Country>
</Grant>
<Grant>
<GrantID>17605</GrantID>
<Agency>Associazione Italiana per la Ricerca sul Cancro</Agency>
<Country>International</Country>
</Grant>
<Grant>
<GrantID>AG034906</GrantID>
<Agency>Associazione Italiana per la Ricerca sul Cancro</Agency>
<Country>International</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>10</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Aging Cell</MedlineTA>
<NlmUniqueID>101130839</NlmUniqueID>
<ISSNLinking>1474-9718</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005609">Free Radicals</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>67763-96-6</RegistryNumber>
<NameOfSubstance UI="D007334">Insulin-Like Growth Factor I</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9002-72-6</RegistryNumber>
<NameOfSubstance UI="D013006">Growth Hormone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D019893">Ribosomal Protein S6 Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.11</RegistryNumber>
<NameOfSubstance UI="D017868">Cyclic AMP-Dependent Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>W36ZG6FT64</RegistryNumber>
<NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D031204" MajorTopicYN="Y">Caloric Restriction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017868" MajorTopicYN="N">Cyclic AMP-Dependent Protein Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018753" MajorTopicYN="Y">Diet, Protein-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005215" MajorTopicYN="N">Fasting</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005609" MajorTopicYN="N">Free Radicals</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013006" MajorTopicYN="N">Growth Hormone</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007334" MajorTopicYN="N">Insulin-Like Growth Factor I</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008017" MajorTopicYN="Y">Life Expectancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000078622" MajorTopicYN="N">Nutrients</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012060" MajorTopicYN="N">Rejuvenation</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019893" MajorTopicYN="N">Ribosomal Protein S6 Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Juventology</Keyword>
<Keyword MajorTopicYN="Y">Longevity</Keyword>
<Keyword MajorTopicYN="Y">aging</Keyword>
<Keyword MajorTopicYN="Y">gerontology</Keyword>
<Keyword MajorTopicYN="Y">healthspan</Keyword>
<Keyword MajorTopicYN="Y">youthspan</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2018</Year>
<Month>05</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>07</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>08</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>10</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>10</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30334314</ArticleId>
<ArticleId IdType="doi">10.1111/acel.12843</ArticleId>
<ArticleId IdType="pmc">PMC6351819</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Nature. 2009 Jul 16;460(7253):392-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19587680</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gerontol A Biol Sci Med Sci. 2011 Feb;66(2):191-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20974732</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2012 Sep 13;489(7415):318-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22932268</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Genet. 2014 May 01;10(5):e1004347</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24785424</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Stem Cell. 2014 Jun 5;14(6):810-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24905167</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Genet. 2005 Nov;6(11):866-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16304601</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Intern Med. 2016 Oct 1;176(10):1453-1463</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27479196</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 May 15;9(5):e97729</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24830393</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Dec 24;462(7276):1061-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19956092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2017 Jan 17;8:14063</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28094793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2014 Apr 01;5:3557</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24691430</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2015 Jul 7;22(1):86-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26094889</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Jul 10;325(5937):201-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19590001</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Top Dev Biol. 2004;63:189-225</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15536017</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 2004 Feb 16;164(4):501-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14970189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2014 Jun 19;157(7):1515-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24949965</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging Cell. 2005 Jun;4(3):119-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15924568</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Physiol Rev. 2013 Apr;93(2):571-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23589828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Genet. 2014 Feb 06;10(2):e1004113</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24516402</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2011 Feb 16;3(70):70ra13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21325617</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2014 Feb 4;19(2):181-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24440038</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2014 Mar 4;19(3):407-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24606898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2018 Jan 26;359(6374):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29371440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 2004 Sep 27;166(7):1055-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15452146</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Italie</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
<li>Lombardie</li>
</region>
<settlement>
<li>Milan</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Longo, Valter D" sort="Longo, Valter D" uniqKey="Longo V" first="Valter D" last="Longo">Valter D. Longo</name>
</region>
<name sortKey="Longo, Valter D" sort="Longo, Valter D" uniqKey="Longo V" first="Valter D" last="Longo">Valter D. Longo</name>
</country>
<country name="Italie">
<region name="Lombardie">
<name sortKey="Longo, Valter D" sort="Longo, Valter D" uniqKey="Longo V" first="Valter D" last="Longo">Valter D. Longo</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000258 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000258 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30334314
   |texte=   Programmed longevity, youthspan, and juventology.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30334314" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020